Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Berges AC"'
Autor:
Cohen-Rabbie S; Clinical Pharmacology and Quantitative Pharmacology, Clinical Pharmacology and Safety Science, AstraZeneca, BioPharmaceuticals R&D, Cambridge, UK., Berges AC; Clinical Pharmacology and Quantitative Pharmacology, Clinical Pharmacology and Safety Science, AstraZeneca, BioPharmaceuticals R&D, Cambridge, UK., Rekić D; Clinical Pharmacology and Quantitative Pharmacology, Clinical Pharmacology and Safety Science, BioPharmaceuticals R&D, Gothenburg, Sweden., Parkinson J; Clinical Pharmacology and Quantitative Pharmacology, Clinical Pharmacology and Safety Science, BioPharmaceuticals R&D, Gothenburg, Sweden., Dota C; Patient Safety Center of Excellence, Oncology R&D, Gothenburg, Sweden., Tomkinson HK; Clinical Pharmacology and Quantitative Pharmacology, Clinical Pharmacology and Safety Science, AstraZeneca, BioPharmaceuticals R&D, Cambridge, UK.
Publikováno v:
Journal of clinical pharmacology [J Clin Pharmacol] 2021 Aug; Vol. 61 (8), pp. 1106-1117. Date of Electronic Publication: 2021 Apr 12.
Autor:
Gottipati G; Department of Pharmaceutical Biosciences, Uppsala University, Box 591, 75124, Uppsala, Sweden., Berges AC; GlaxoSmithKline, London, UK.; Quantitative Clinical Pharmacology, Early Clinical Development, IMED Biotech Unit, AstraZeneca, Cambridge, UK., Yang S; GlaxoSmithKline, London, UK., Chen C; GlaxoSmithKline, London, UK., Karlsson MO; Department of Pharmaceutical Biosciences, Uppsala University, Box 591, 75124, Uppsala, Sweden., Plan EL; Department of Pharmaceutical Biosciences, Uppsala University, Box 591, 75124, Uppsala, Sweden. elodie.plan@farmbio.uu.se.
Publikováno v:
Pharmaceutical research [Pharm Res] 2019 Jul 17; Vol. 36 (9), pp. 135. Date of Electronic Publication: 2019 Jul 17.
Autor:
Richards DB; From GlaxoSmithKline Research and Development, Stevenage (D.B.R., L.M.C., A.C.B., S.V.B.), and National Health Service National Amyloidosis Centre, Centre for Amyloidosis and Acute Phase Proteins, University College London (UCL) and Royal Free Hospital (T.L., M.F., J.D.G., P.N.H., M.B.P.), Quintiles Drug Research Unit at Guy's Hospital (J.M.R.), and UCL Division of Medicine (M.F.), UCL Institute of Cardiovascular Science and Barts Heart Centre (J.C.M.), UCL Institute for Liver and Digestive Health (M.P.), and UCL Wolfson Drug Discovery Unit (M.B.P.), University College London, London - all in the United Kingdom., Cookson LM, Berges AC, Barton SV, Lane T, Ritter JM, Fontana M, Moon JC, Pinzani M, Gillmore JD, Hawkins PN, Pepys MB
Publikováno v:
The New England journal of medicine [N Engl J Med] 2015 Sep 17; Vol. 373 (12), pp. 1106-14. Date of Electronic Publication: 2015 Jul 15.
Autor:
Grove RA, Harrington CM, Mahler A, Beresford I, Maruff P, Lowy MT, Nicholls AP, Boardley RL, Berges AC, Nathan PJ, Horrigan JP; Neurosciences Therapeutic Area, GlaxoSmithKline, Five Moore Drive, Research Triangle Park, NC, 27709, USA. conn.m.harrington@gsk.com.
Publikováno v:
Current Alzheimer research [Curr Alzheimer Res] 2014 Jan; Vol. 11 (1), pp. 47-58.